-transparent.png){kind=logo}
BACKGROUND Autoimmune thrombocytopenic purpura is a common disease during pregnancy. Newborns of affected mothers commonly develop thrombocytopenia. Standard therapy consists of corticosteroids, hyperimmune gamma globulin and splenectomy. METHODS Severe autoimmune thrombocytopenic purpura was diagnosed in a 22-year-old woman, gravida 2, para 1, at 28 weeks' gestation. A sufficient response was obtained after vincristine was added to the treatment with corticosteroids, hyperimmune gamma globulin and danazole. A male infant weighing 2,545 g was delivered by cesarean section at 33.5 weeks' gestation. There were no maternal or fetal complications except for severe newborn thrombocytopenia, which resolved with medical therapy. CONCLUSIONS Vincristine has been used in all trimesters of pregnancy, with favorable outcomes in most cases. This is the first reported case of successful vincristine treatment for autoimmune thrombocytopenic purpura in pregnancy. Vincristine, when carefully used, offers an option for unusually refractory cases of autoimmune thrombocytopenic purpura before delivery.
Z Gross, and
J J Rodriguez, and
B L Stalnaker
January 1992,
Minerva ginecologica,
Z Gross, and
J J Rodriguez, and
B L Stalnaker
November 1982,
Blood,
Z Gross, and
J J Rodriguez, and
B L Stalnaker
January 1981,
Terapevticheskii arkhiv,
Z Gross, and
J J Rodriguez, and
B L Stalnaker
August 1979,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Z Gross, and
J J Rodriguez, and
B L Stalnaker
January 1991,
Acta haematologica,
Z Gross, and
J J Rodriguez, and
B L Stalnaker
April 1982,
Annals of the Academy of Medicine, Singapore,
Z Gross, and
J J Rodriguez, and
B L Stalnaker
November 1999,
Annals of hematology,
Z Gross, and
J J Rodriguez, and
B L Stalnaker
March 1991,
Clinical obstetrics and gynecology,
Z Gross, and
J J Rodriguez, and
B L Stalnaker
February 1991,
Lancet (London, England),
Z Gross, and
J J Rodriguez, and
B L Stalnaker
July 2008,
Ginekologia polska,
